NeuroClick : software for mimicking click reaction to generate drug-like molecules permeating the blood-brain barrier
Background: Traditional methods for chemical library generation in virtual screening often impose limitations on the accessible chemical space or produce synthetically irrelevant structures. Incorporating common chemical reactions into generative algorithms could offer significant benefits. Materials & methods: In this study, we developed NeuroClick, a graphical user interface software designed to perform in silico azide-alkyne cycloaddition, a widely utilized synthetic approach in modern medicinal chemistry. Results & conclusion: NeuroClick facilitates the generation and filtering of large combinatorial libraries at a remarkable rate of 10,000 molecules per minute. Moreover, the generated products can be filtered to identify subsets of pharmaceutically relevant compounds based on Lipinski's rule of five and blood-brain barrier permeability prediction. We demonstrate the utility of NeuroClick by generating and filtering several thousand molecules for dopamine D3 receptor ligand screening.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2024 |
---|---|
Erschienen: |
2024 |
Enthalten in: |
Zur Gesamtaufnahme - volume:16 |
---|---|
Enthalten in: |
Future medicinal chemistry - 16(2024), 5 vom: 19. Feb., Seite 389-398 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Isakova, Anastasiia M [VerfasserIn] |
---|
Links: |
---|
Themen: |
Blood–brain barrier |
---|
Anmerkungen: |
Date Completed 27.02.2024 Date Revised 27.02.2024 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.4155/fmc-2023-0017 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM368622002 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | NLM368622002 | ||
003 | DE-627 | ||
005 | 20240229164446.0 | ||
007 | cr uuu---uuuuu | ||
008 | 240219s2024 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.4155/fmc-2023-0017 |2 doi | |
028 | 5 | 2 | |a pubmed24n1309.xml |
035 | |a (DE-627)NLM368622002 | ||
035 | |a (NLM)38372134 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Isakova, Anastasiia M |e verfasserin |4 aut | |
245 | 1 | 0 | |a NeuroClick |b software for mimicking click reaction to generate drug-like molecules permeating the blood-brain barrier |
264 | 1 | |c 2024 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 27.02.2024 | ||
500 | |a Date Revised 27.02.2024 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Background: Traditional methods for chemical library generation in virtual screening often impose limitations on the accessible chemical space or produce synthetically irrelevant structures. Incorporating common chemical reactions into generative algorithms could offer significant benefits. Materials & methods: In this study, we developed NeuroClick, a graphical user interface software designed to perform in silico azide-alkyne cycloaddition, a widely utilized synthetic approach in modern medicinal chemistry. Results & conclusion: NeuroClick facilitates the generation and filtering of large combinatorial libraries at a remarkable rate of 10,000 molecules per minute. Moreover, the generated products can be filtered to identify subsets of pharmaceutically relevant compounds based on Lipinski's rule of five and blood-brain barrier permeability prediction. We demonstrate the utility of NeuroClick by generating and filtering several thousand molecules for dopamine D3 receptor ligand screening | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a blood–brain barrier | |
650 | 4 | |a chemoinformatics | |
650 | 4 | |a click chemistry | |
650 | 4 | |a library design | |
650 | 4 | |a virtual screening | |
700 | 1 | |a Kovalenko, Alexander A |e verfasserin |4 aut | |
700 | 1 | |a Skorb, Ekaterina V |e verfasserin |4 aut | |
700 | 1 | |a Shityakov, Sergey |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Future medicinal chemistry |d 2009 |g 16(2024), 5 vom: 19. Feb., Seite 389-398 |w (DE-627)NLM194822109 |x 1756-8927 |7 nnns |
773 | 1 | 8 | |g volume:16 |g year:2024 |g number:5 |g day:19 |g month:02 |g pages:389-398 |
856 | 4 | 0 | |u http://dx.doi.org/10.4155/fmc-2023-0017 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 16 |j 2024 |e 5 |b 19 |c 02 |h 389-398 |